Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod (Q44241584)

1 December 2017

title

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod (English)

1 reference

1 December 2017

0 references

1 reference

Sheila J Gibson

1 reference

1 December 2017

Jana M Lindh

1 reference

1 December 2017

Tony R Riter

1 reference

1 December 2017

Raymond M Gleason

1 reference

1 December 2017

Lisa M Rogers

1 reference

1 December 2017

Ashley E Fuller

1 reference

1 December 2017

JoAnn L Oesterich

1 reference

1 December 2017

Keith B Gorden

1 reference

1 December 2017

Xiaohong Qiu

1 reference

1 December 2017

Scott W McKane

1 reference

1 December 2017

Randy J Noelle

1 reference

1 December 2017

Richard L Miller

1 reference

1 December 2017

Ross M Kedl

1 reference

1 December 2017

Patricia Fitzgerald-Bocarsly

1 reference

1 December 2017

Mark A Tomai

1 reference

1 December 2017

John P Vasilakos

1 reference

1 December 2017

publication date

1 July 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

218

1 reference

1 December 2017

issue

1-2

1 reference

1 December 2017

page(s)

74-86

1 reference

Dendritic cells and the control of immunity

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Differential regulation of human blood dendritic cell subsets by IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Proliferating dendritic cell progenitors in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

The nature of the principal type 1 interferon-producing cells in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Type I interferons keep activated T cells alive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Cytokine research: the interferon paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Lymphokine control of in vivo immunoglobulin isotype selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Immunomodulating and antiviral activities of the imidazoquinoline S-28463.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Reciprocal control of T helper cell and dendritic cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Immunobiology of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Functions of CD40 on B cells, dendritic cells and other cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Adjuvant activities of immune response modifier R-848: comparison with CpG ODN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

Imiquimod applied topically: a novel immune response modifier and new class of drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0008-8749%2802%2900517-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0008-8749(02)00517-8

1 reference

1 December 2017

1 reference